Caricamento...
Phosphoinositide 3‐kinase δ is a regulatory T‐cell target in cancer immunotherapy
Tumour infiltration by regulatory T (Treg) cells contributes to suppression of the anti‐tumour immune response, which limits the efficacy of immune‐mediated cancer therapies. The phosphoinositide 3‐kinase (PI3K) pathway has key roles in mediating the function of many immune cell subsets, including T...
Salvato in:
| Pubblicato in: | Immunology |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587315/ https://ncbi.nlm.nih.gov/pubmed/31107985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.13082 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|